Atherosclerosis as an inflammatory disease

Area of Science:

• Cardiovascular Biology
• Immunology
• Inflammation Research

Background:

• Atherosclerosis is increasingly recognized as a chronic inflammatory disorder.
• Recent research highlights the critical role of chemokines and immune cell accumulation in disease pathogenesis.
• The CD40-CD40 ligand (CD40L) pathway is implicated in immune responses within atherosclerotic lesions.

Purpose of the Study:

• To elucidate the mechanisms of immune cell involvement in atherosclerosis.
• To investigate the function of CD40 and CD40L in activating atheroma-associated cells.
• To explore novel therapeutic strategies targeting the inflammatory aspects of atherosclerosis.

Main Methods:

• Review of recent studies on chemokines, leukocyte recruitment, and immune cell functions in atherosclerosis.
• Analysis of CD40 and CD40L expression in vascular endothelial cells, smooth muscle cells, and macrophages.
• Examination of the role of CD40L in promoting the expression of adhesion molecules, cytokines, and other pro-atherogenic factors.

Main Results:

• CD40 and CD40L are coexpressed by key cells in human atherosclerotic lesions.
• CD40L activation of atheroma-associated cells promotes the expression of adhesion molecules, cytokines, matrix metalloproteinases, and tissue factor.
• Innate and adaptive immune responses, involving macrophages and T-lymphocytes, are central to atherosclerosis progression.

Conclusions:

• Contact-dependent interaction between CD40 and CD40L stimulates atheroma-associated cells.
• Macrophages play a pivotal role in plaque instability and progression.
• Targeting the inflammatory component of atherosclerosis presents a promising therapeutic avenue.